Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Procyon receives Canadian patent for PSP94

March 30, 1999

AltaRex updates OvaRex MAb and BrevaRex MAb clinical progress

March 29, 1999

Maxim allowed additional U.S. patent for Maxamine technology

March 22, 1999

Mouse study provides preliminary indications of the antitumor efficacy of AR-209

March 18, 1999

Clinical trials of needle-free delivery of DNA vaccine begin

March 18, 1999

Second prostate cancer study initiated with Multikine

March 16, 1999

Genzyme Molecular Oncology initiates clinical trials of combined-antigen melanoma vaccine

March 10, 1999

Techniclone to present clinical data on newly designated orphan drug at ASCO

March 10, 1999

Betathine approved for accelerated phase I/II trials in Canada

March 2, 1999

ImmunoGen discusses progress of tumor-activated prodrugs

March 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...